| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$998,506 ) |
| | 2025 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA287952 | An integrated microfluidic device for patient-derived micro-organospheres | 000 | 1 | NIH | 2/3/2025 | $0 |
| | 2025 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA261579 | Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | 000 | 2 | NIH | 10/10/2024 | -$998,506 |
|
| Issue Date FY: 2024 ( Subtotal = $1,239,153 ) |
| | 2024 | 2024 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA287952 | An integrated microfluidic device for patient-derived micro-organospheres | 002 | 2 | NIH | 9/12/2024 | $1,239,153 |
| | 2024 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA287952 | An integrated microfluidic device for patient-derived micro-organospheres | 001 | 1 | NIH | 1/31/2024 | $0 |
| | 2024 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA287952 | An integrated microfluidic device for patient-derived micro-organospheres | 000 | 1 | NIH | 10/13/2023 | $0 |
| | 2024 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA261579 | Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | 001 | 2 | NIH | 8/2/2024 | $0 |
| | 2024 | 2022 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA261579 | Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | 000 | 1 | NIH | 5/2/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,398,244 ) |
| | 2023 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA261579 | Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | 000 | 2 | NIH | 9/1/2023 | $998,506 |
| | 2023 | 2023 | XILIS INC | 31 ALEXANDRIA WAY | DURHAM | NC | 27703 | DURHAM | USA | R44CA287952 | An integrated microfluidic device for patient-derived micro-organospheres | 000 | 1 | NIH | 9/20/2023 | $399,738 |
|
| Issue Date FY: 2022 ( Subtotal = $398,486 ) |
| | 2022 | 2022 | XILIS, INC. | 113 EASTWOOD LAKE RD | CHAPEL HILL | NC | 27514-7500 | ORANGE | USA | R44CA261579 | Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy | 000 | 1 | NIH | 5/6/2022 | $398,486 |
|
|
